2025
SJR Q2
JCR Q4 · 1,6
20 matched articles
SCIE
Journal detail
Journal of Adolescent and Young Adult Oncology
- Publisher
- Mary Ann Liebert Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
215653332156535X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,629
- Quartile Q2
- H-Index 39
- Cites/doc 1,81
- Docs (3y) 302
- Cites (3y) 540
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,6
- 5Y JIF 1,9
- JCI 0,29
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Oncology Q3
- Pediatrics, Perinatology and Child Health Q2
Areas
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q4 | 0,629 | 1,6 | 1,9 | 0,29 | Q4 | 39 |
| 2024 | Q1 | Q4 | 0,788 | 1,2 | 1,7 | 0,3 | Q4 | 35 |
| 2023 | Q1 | Q4 | 0,845 | 1,2 | 2,5 | 0,32 | Q4 | 35 |
| 2022 | Q2 | Q4 | 0,625 | 2 | 2,2 | 0,32 | Q4 | 35 |
| 2021 | Q2 | Q4 | 0,704 | 1,8 | 2,3 | 0,33 | Q4 | 35 |
| 2020 | Q2 | Q4 | 0,743 | 2,2 | 2,8 | 0,43 | Q4 | 35 |
| 2019 | Q1 | Q4 | 0,915 | 1,6 | 2,1 | 0,48 | Q3 | 35 |
| 2018 | — | Q3 | — | 2,4 | 2,7 | 0,58 | Q3 | — |
| 2017 | Q2 | Q4 | 0,721 | 2,2 | 2,2 | 0,42 | Q3 | 35 |
| 2016 | Q3 | Q4 | 0,306 | 1,4 | 1,9 | — | — | 35 |
| 2015 | Q4 | Q4 | 0,123 | 1,1 | 1,4 | — | — | 35 |
| 2014 | — | — | — | — | — | — | — | 35 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q4 | Q4 | 280/333 |
| 2024 | ONCOLOGY | SCIE | Q4 | Q4 | 280/328 |
| 2023 | ONCOLOGY | SCIE | Q4 | Q4 | 273/322 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q4 | 211/241 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q4 | 228/245 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q4 | 219/242 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 225/244 |
| 2018 | ONCOLOGY | SCIE | Q3 | Q3 | 159/230 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q3 | 168/223 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 190/217 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 193/213 |